Company
ChinaZhejiang Starry Pharmaceutical Co. Ltd., Taizhou, China – FDA Inspections
Inspection records and compliance data for Zhejiang Starry Pharmaceutical Co. Ltd. in Taizhou. 2 FDA inspections on record, 1 Form 483, last inspected September 06, 2024.
Company Profile
This profile covers Zhejiang Starry Pharmaceutical Co. Ltd. based in Taizhou, China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected August 2, 2019. Last inspected September 6, 2024.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| September 6, 2024 | NAI | Human Drugs · Drug Quality Assurance | 1252246 |
| August 2, 2019 | VAI | Human Drugs · Drug Quality Assurance | 1098549 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
KinOmega Biopharm Inc.
Tianjin Jinjin Pharmaceutical Co. Ltd.
JQC (Huayin) Pharmaceutical Co., Ltd.
Sichuan Renan Pharmaceutical Co., Ltd
Lianhe Aigen Pharma Co, Ltd.
Topharman Shandong Co., Ltd.
Wuhan Calmland Pharmaceuticals Co., Ltd.
Viwit Pharmaceutical Co., Ltd.
Shandong Jincheng Kunlun Pharmaceutical Co., Ltd.
Jiangsu Jiafu Pharmaceutical Co., Ltd.
Company Information
Name
Zhejiang Starry Pharmaceutical Co. Ltd.
FEI Number
3007027206
Address
No. 1 Starry Road Of Xianju Modern Industrial, Centralization Zone, Taizhou, China
Country
China
ID: eb59f9e2-22be-43f3-be3c-de1dbf375209